Pres Trump: Contract to Company to Make Coronavirus Drugs in US; Drop in Cases as States Reopen, and Other Coronavirus Updates

Jonathan Ernst/Reuters

President Trump has awarded a major contract to a Virginia company to manufacture Covid treatments in the U.S.

The $354 million four-year contract was awarded to Virginia-based Phlow Corp. by Health and Human Services’ Biomedical Advanced Research and Development Authority to make pharmaceutical ingredients and medicines related to the coronavirus. The company says it is manufacturing ingredients and finished dosage forms for more than a dozen medicines to treat the virus, many of which are in short supply and were previously made in India and China and imported.

LINK: Trump cheers drop in COVID-19 cases as states

reopen

“This is an historic turning point in America’s efforts to onshore its pharmaceutical production and supply chains,” White House trade adviser Peter Navarro said, adding that the contract “will not only help bring our essential medicines home but actually do so in a way that is cost competitive with the sweatshops and pollution havens of the world.”

The contract could potentially be extended to $812 million over 10 years.

Read the rest of the story HERE and follow links below to related stories and resources:

Trump cheers drop in COVID-19 cases as states reopen

Trump announces $16 billion in direct payments for farmers hurt by pandemic 'caused by China'

USA TODAY: Coronavirus live updates: More fallout from Trump taking unproven hydroxychloroquine; Pier 1 to close all stores

WSJ: Coronavirus Updates: Walmart’s Sales Surge; Airlines See More Bookings

YAHOO NEWS: Coronavirus live updates: More fallout from Trump taking unproven hydroxychloroquine; Pier 1 to close all stores

NEW YORK POST: Today’s coronavirus update: State data under scrutiny; a live concert looks tame

If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.